814 results on '"Hoshino, Tomoaki"'
Search Results
2. Soluble form of the MDA5 protein in human sera
3. A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib
4. Correction to: clinical significance of high monocyte counts for the continuous treatment with nintedanib
5. Clinical significance of high monocyte counts for the continuous treatment with nintedanib
6. Enhanced immune complex formation in the lungs of patients with dermatomyositis
7. Obesity may be a risk factor for transbronchial lung cryobiopsy-related adverse events in Japanese patients with interstitial lung disease
8. Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer
9. Sensitivity of transbronchial lung cryobiopsy in the diagnosis of different interstitial lung diseases
10. Airway hyperresponsiveness and inflammation in Japanese patients with human immunodeficiency virus 1 infection
11. Examination of prognostic factors in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
12. Altered Functional Connectivity during Mild Transient Respiratory Impairment Induced by a Resistive Load
13. Characterization of Pre- and Post-treatment Soluble Immune Mediators and the Tumor Microenvironment in NSCLC Patients Receiving PD-1/L1 Inhibitor Monotherapy
14. Clinical significance of peripheral TCR and BCR repertoire diversity in EGFR/ALK wild-type NSCLC treated with anti-PD-1 antibody
15. Comparative incidence of immune-related adverse events and hyperprogressive disease in patients with non-small cell lung cancer receiving immune checkpoint inhibitors with and without chemotherapy
16. Overweight improves long-term survival in Japanese patients with asthma
17. IL-18 receptor-α signalling pathway contributes to autoantibody-induced arthritis via neutrophil recruitment and mast cell activation.
18. Ability of Periostin as a New Biomarker of Idiopathic Pulmonary Fibrosis
19. Characteristics of tobacco-related lung diseases in Fukuoka Prefecture, Japan: A prospective, multi-institutional, observational study
20. A Case in which Eosinophilic Meningoencephalitis Occurred during Oral Corticosteroid Tapering and after Switching from Anti-IL-5 to Anti-IgE Treatment
21. Interleukin-38 promotes tumor growth through regulation of CD8+ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment
22. Acute exacerbation of idiopathic pulmonary fibrosis after bivalent (tozinameran and famtozinameran) mRNA COVID-19 vaccination
23. Endobronchial cryptococcosis with bronchial stenosis in a patient with severe asthma treated with inhaled corticosteroids: A case report
24. Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
25. Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case Report
26. MO55-4 Prognostic impact and predictive biomarkers of immune checkpoint inhibitor-induced interstitial lung disease for non-small cell lung cancer
27. Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy
28. Impact of airflow obstruction on long-term mortality in patients with asthma in Japan
29. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis
30. Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors
31. Overweight improves long-term survival in Japanese patients with asthma
32. Five-year follow up analysis of Japanese ILD registry
33. Poor asthma control in schoolchildren may lead to lower lung function trajectory from childhood to early adulthood: A japanese cohort study
34. Combination of Prednisolone and Calcineurin Inhibitors Prevents Lung Function Decline in Patients with Anti-aminoacyl-tRNA Synthetase Antibody-Positive Polymyositis/Dermatomyositis
35. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
36. IL-33/ST2 contributes to severe symptoms in Plasmodium chabaudi-infected BALB/c mice
37. Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients
38. A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma
39. Pyoderma gangrenosum, acne, and unclassified inflammatory bowel disease syndrome: A case report on a new subtype of pyogenic arthritis, pyoderma gangrenosum, and acne syndrome
40. The Characteristic of Transbronchial Lung Cryobiopsy in the Pathological Diagnosis of Hypersensitivity Pneumonitis
41. IL-18 receptor-α signalling pathway contributes to autoantibody-induced arthritis via neutrophil recruitment and mast cell activation
42. Overexpression of IL-38 protein in anticancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis
43. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease
44. Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib
45. A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease
46. Prognostic effect of cachexia in patients with non‐small cell lung cancer receiving immune checkpoint inhibitors
47. Supplementary Figure S1 from Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer
48. Table S1 from Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity
49. Figure S6 from Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity
50. Supplementary Table S1 from Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.